GW Pharmaceuticals Ltd clinical trials
Acquired by Jazz Pharmaceuticals, May 5, 2021 · source ↗
The registry lists 7 studies whose lead sponsor is GW Pharmaceuticals Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 5, 2021.
Before and after it joined Jazz Pharmaceuticals
- First submitted before GW Pharmaceuticals Ltd became part of Jazz Pharmaceuticals
- 7
- First submitted after GW Pharmaceuticals Ltd became part of Jazz Pharmaceuticals
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- GW Pharmaceuticals Ltd7 studies
Something wrong with this grouping? Tell us on the Jazz Pharmaceuticals page.
Studies
Recruiting first, then most recently updated. Showing 7 of 7. All Jazz Pharmaceuticals studies →
- A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy SubjectsTerminatedNCT02240160Phase 1
Sponsor listed in the registry: GW Pharmaceuticals Ltd · First submitted before GW Pharmaceuticals Ltd became part of Jazz Pharmaceuticals
- Sativex® for Relieving Persistent Pain in Participants With Advanced CancerCompletedNCT01262651Phase 3
Sponsor listed in the registry: GW Pharmaceuticals Ltd · First submitted before GW Pharmaceuticals Ltd became part of Jazz Pharmaceuticals
- A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.WithdrawnNCT02325024Phase 1
Sponsor listed in the registry: GW Pharmaceuticals Ltd · First submitted before GW Pharmaceuticals Ltd became part of Jazz Pharmaceuticals
- A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced MucositisTerminatedNCT01975688Phase 1
Sponsor listed in the registry: GW Pharmaceuticals Ltd · First submitted before GW Pharmaceuticals Ltd became part of Jazz Pharmaceuticals
- A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced CancerWithdrawnNCT02432612Phase 1
Sponsor listed in the registry: GW Pharmaceuticals Ltd · First submitted before GW Pharmaceuticals Ltd became part of Jazz Pharmaceuticals
- Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MSCompletedNCT00391079Phase 3
Sponsor listed in the registry: GW Pharmaceuticals Ltd · First submitted before GW Pharmaceuticals Ltd became part of Jazz Pharmaceuticals
- A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.CompletedNCT00530764Phase 2
Sponsor listed in the registry: GW Pharmaceuticals Ltd · First submitted before GW Pharmaceuticals Ltd became part of Jazz Pharmaceuticals